Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.
Completed
Conditions studied: Chronic Hepatitis B
In brief
To determine whether HBeAg-positive and HBeAg-negative patients with HBV DNA greater than or less than 5 log10 and 4 log10 copies/mL, respectively, and with normal or minimally elevated liver transaminases have histological evidence of active liver disease.
Key facts
- Study ID
- NCT00263614
- Run by
- Gilead Sciences
- People needed
- 100
- Starts
- 2005-12-01
- Expected to finish
- 2007-06-01
- Last updated by the study team
- 2009-02-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Gilead Sciences, Inc. — Foster City, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.